Falko Friedrichs is ranked #503 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Analyst Tracker/Falko Friedrichs

Falko Friedrichs

Q: How accurate are Falko Friedrichs's stock ratings?

About 70% of Falko's ratings were profitable over a one-year hold, with an average return of +8.1% per rating, measured by 13Foresight from historical prices.

Deutsche Bank

Wall Street Analyst

★★★★☆

#503

on 13Foresight · ranked by our own returns

68%

Success Rate

+7.8%

Average Return

34 of 50 calls profitable · -5.9% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 68% of Falko Friedrichs's ratings turned a profit when each position was held for 2 year — averaging +7.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

42 Buy 68 Hold 0 Sell

Falko's Stock Coverage 34 ratings · 2026-08-05

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	2-Yr Return	vs S&P 500 ⓘ
DE:GXI Gerresheimer	Aug 04, 2026	HOLD	Buy +127.4% avg upside 16 analysts	$26.00 4.82% Downside	·	·
DE:FME Fresenius Medical Care AG & Co. KGaA	Aug 04, 2026	HOLD	Hold +20.3% avg upside 23 analysts	$40.00 3.61% Downside	·	·
DE:SHL Siemens Healthineers AG	Aug 03, 2026	HOLD	Buy +25.9% avg upside 24 analysts	$38.00 2.48% Downside	·	·
FR:EL EssilorLuxottica SA	Aug 03, 2026	HOLD	Strong Buy +6.8% avg upside 17 analysts	$174.00 2.10% Upside	·	·
NL:PHIA Koninklijke Philips N.V.	Jul 30, 2026	HOLD	Buy +32.9% avg upside 21 analysts	$24.00 4.89% Upside	·	·
DE:SRT3 Sartorius	Jul 28, 2026	BUY	Buy +21.0% avg upside 18 analysts	$284.00 24.74% Upside	-1.5%	·
CH:LONN Lonza Group Ltd	Jul 28, 2026	BUY	Strong Buy +15.9% avg upside 21 analysts	$697.00 25.21% Upside	-0.8%	·
DE:MRK Merck KGaA	Jul 23, 2026	HOLD	Buy -6.6% avg upside 33 analysts	$125.00 14.50% Downside	+2.7%	·
DE:FRE Fresenius SE & Co. KGaA	Jul 20, 2026	BUY	Strong Buy +12.8% avg upside 20 analysts	$55.00 24.05% Upside	+2.0%	·
DE:OBCK Ottobock SE & Co. KGaA	Jul 15, 2026	BUY	Strong Buy +46.9% avg upside 4 analysts	$83.00 45.18% Upside	-1.7%	·
DE:AFX Carl Zeiss Meditec	Jul 14, 2026	HOLD	Hold +51.7% avg upside 13 analysts	$28.00 9.62% Downside	+3.7%	·
IT:1SXP SCHOTT Pharma AG & Co. KGaA	Jul 09, 2026	BUY	Strong Buy -3.2% avg upside 6 analysts	$23.00 5.30% Upside	+5.0%	·
WILLF Demant	Jul 06, 2026	HOLD	Buy -5.9% avg upside 19 analysts	$39.81 10.21% Downside	+9.6%	·
SE:EKTA.B Elekta AB	Jun 22, 2026	HOLD	Sell +22.1% avg upside 12 analysts	$52.00 5.73% Upside	+1.9%	·
CH:ALC Alcon	May 12, 2026	BUY	Buy +24.9% avg upside 35 analysts	$70.00 22.25% Upside	+13.1%	·
CH:SOON Sonova Holding AG	Mar 25, 2026	HOLD	Hold -3.0% avg upside 18 analysts	$188.00 18.49% Downside	+28.6%	·
DE:BAYN Bayer	Mar 05, 2026	HOLD	Strong Buy +6.2% avg upside 30 analysts	$23.00 52.25% Downside	+33.5%	·
CH:STMN Straumann Holding AG	Oct 01, 2025	HOLD	Buy +22.2% avg upside 15 analysts	$99.00 4.75% Downside	+17.3%	·
GB:0QBO Coloplast A/S	Sep 08, 2025	HOLD	Buy +67.4% avg upside 17 analysts	$660.00 50.84% Upside	·	·
QGEN Qiagen	Apr 07, 2025	BUY	Buy -0.6% avg upside 24 analysts	$49.47 17.52% Upside	+4.3%	·
BR:A2LC34 Alcon Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh	Mar 31, 2025	BUY	Strong Buy +1595.5% avg upside 1 analyst	$602.24 1595.47% Upside	·	·
DE:EVT Evotec	Nov 25, 2024	SELL	Buy +378.0% avg upside 8 analysts	$4.00 15.98% Upside	+61.8%	·
EVO Evotec AG	Apr 12, 2024	BUY	Buy +330.5% avg upside 9 analysts	$19.00 876.84% Upside	-63.9%	·
FR:EAPI Euroapi SA	Jan 25, 2024	HOLD	Buy +701.3% avg upside 5 analysts	$6.00 490.62% Upside	-66.7%	·
DE:SRT Sartorius	Oct 04, 2023	BUY	Strong Buy +104.2% avg upside 5 analysts	$414.00 124.35% Upside	-29.1%	·
DE:SBS STRATEC Biomedical	Mar 13, 2023	HOLD	Buy +192.8% avg upside 5 analysts	$71.00 248.93% Upside	-57.9%	·
BBLNF Babylon Holdings	Aug 23, 2022	BUY	Buy +65549900.0% avg upside 6 analysts	$125.00 124999899.96% Upside	·	·
DE:BNN B.R.A.I.N. Biotechnology Research and Information Network	Oct 20, 2021	BUY	Strong Buy +204.8% avg upside 3 analysts	$13.00 359.46% Upside	-57.5%	·
FMS Fresenius Medical Care	Feb 03, 2021	HOLD	Hold +85.9% avg upside 14 analysts	—	-42.7%	·
DE:FNTN freenet	Feb 02, 2021	HOLD	Buy +7.6% avg upside 19 analysts	$21.00 13.27% Downside	+37.6%	·
CH:UBSG UBS Group AG	Apr 29, 2020	HOLD	Buy -22.9% avg upside 25 analysts	$9.00 79.18% Downside	+82.1%	·
GB:AZN AstraZeneca	Sep 09, 2019	BUY	Strong Buy +24.5% avg upside 26 analysts	$7800.00 33.50% Downside	+19.4%	·
DE:DRW3 Draegerwerk AG & Co. KGaA	Aug 14, 2019	HOLD	Buy -31.1% avg upside 2 analysts	$46.00 59.52% Downside	+97.2%	·
DE:DRW8 Draegerwerk AG & Co. KGaA	Aug 14, 2019	HOLD	Hold -42.1% avg upside 3 analysts	$46.00 45.47% Downside	+125.4%	·

🔒 29 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Falko Friedrichs — Frequently Asked Questions

How accurate are Falko Friedrichs's stock ratings?

Based on the calls 13Foresight could measure, about 70% of Falko's ratings were profitable over a one-year hold, with an average return of +8.1% per rating, or -0.7% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Falko ranked on 13Foresight?

Falko Friedrichs is currently ranked #503 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Falko cover?

Falko most recently has ratings on DE:GXI, DE:FME, DE:SHL, FR:EL, NL:PHIA, DE:SRT3, CH:LONN, DE:MRK, DE:FRE, DE:OBCK, DE:AFX, IT:1SXP and 22 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Falko Friedrichs

Rating Distribution

Welcome to 13Foresight!